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jjInstitute of Organic Chemistry and CFN, Karlsruhe Institute of Technology, Karlsruhe, GermanyABSTRACT The membrane-active antimicrobial peptide PGLa from Xenopus laevis is known from solid-state 2H-, 15N-,
and 19F-NMR spectroscopy to occupy two distinct a-helical surface adsorbed states in membranes: a surface-bound S-state
with a tilt angle of ~95 at low peptide/lipid molar ratio (P/L ¼ 1:200), and an obliquely tilted T-state with a tilt angle of 127 at
higher peptide concentration (P/L ¼ 1:50). Using a rapid molecular-dynamics insertion protocol in combination with micro-
second-scale simulation, we have characterized the structure of both states in detail. As expected, the amphiphilic peptide
resides horizontally on the membrane surface in a monomeric form at a low P/L, whereas the T-state is seen in the simulations
to be a symmetric antiparallel dimer, with close contacts between small glycine and alanine residues at the interface. The
computed tilt angles and azimuthal rotations, as well as the quadrupolar splittings predicted from the simulations agree with
the experimental NMR data. The simulations reveal many structural details previously inaccessible, such as the immersion
depth of the peptide in the membrane and the packing of the dimerization interface. The study highlights the ability and limita-
tions of current state-of-the-art multimicrosecond all-atom simulations of membrane-active peptides to complement experi-
mental data from solid-state NMR.INTRODUCTIONSmall membrane-active antimicrobial peptides (AMPs) are
found in many organisms as part of the innate immune
system, defending the host against invading bacteria and
other microorganisms (1,2). AMPs have been proposed
as a potential source of new antibiotics against increasingly
common multiresistant pathogens, as they are unlikely to
induce resistance. Most of these peptides kill bacteria by
physically interacting with and disrupting their cell mem-
branes. However, the exact molecular mechanism by which
this occurs is not fully understood at present. The high
affinity of AMPs for lipid bilayers is attributed to their over-
all amphiphilic structure.
PGLa, from the skin of the African frog Xenopus laevis
(Fig. 1) (3–5), is part of the ‘‘magainin family’’ of peptides
that exhibit broad antimicrobial activity (6). In addition to
antibacterial properties (7), it has been reported that PGLa
and other related AMPs show anticancer (8), antiviral (9),
and antifungal activity (10). Detailed knowledge of the
membrane-bound structure of PGLa is sparse, with most
information derived indirectly from activity assays and fluo-
rescence anddye-release experiments (11,12). The antimicro-
bial activity is generally attributed to the formation of pores
in the membrane at high peptide/lipid molar ratios (P/Ls).
Recently, substantial progress has been made in the deter-
mination of the structure of PGLa and related peptides in
oriented lipid bilayers using solid-state 2H-, 15N-, and 19F-
NMR spectroscopy (12–23). These measurements have re-Submitted March 22, 2012, and accepted for publication June 28, 2012.
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It resides in a well-defined surface-bound S-state in 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) bilayers
at P/L ¼ 1:200 and below, at which ratio the peptide is
presumed to be monomeric. Under these conditions it has
a tilt angle (the angle between the helix long-axis vector,
pointing from the N- to the C-terminus, and the mem-
brane normal) of t z 95 and an azimuthal rotation angle
(the angle by which the peptide is rotated around its
long axis) of rz 116. This S-state is common for amphi-
pathic helices at low P/L and has been found for many other
related antimicrobial peptides (6). Upon increasing the pep-
tide concentration, PGLa is thought to form pores in a trans-
membrane configuration (16). However, an inserted state
could only be detected at artificially low temperatures in
gel-phase bilayers (24), or when stabilized by its synergistic
partner magainin 2 (MAG2) (16). That is because pure
PGLa presumably forms pores only transiently, with life-
times too short to be studied by NMR (21). Nevertheless,
19F- and 2H-NMR data of PGLa in DMPC have shown a
critical realignment step that is considered to be the first
functionally relevant event in membrane permeabilization.
Upon increasing the PGLa concentration to P/L ¼ 1:50,
a transition occurs from the monomeric S-state to an
obliquely tilted T-state, with a distinct set of angles, t z
127 and rz 111 (13,16,19,21). Experimentally, theT-state
is stable over a wide range of peptide concentrations from
1:100 up to 1:20, and it is independent of lipid
charge, being detected also in the presence of DMPG (21).
This discrete T-state had not been known before the compre-
hensive NMR analysis of PGLa, but it was subsequentlyhttp://dx.doi.org/10.1016/j.bpj.2012.06.040
FIGURE 1 Illustration of a high-temperature
peptide insertion simulation for monomeric PGLa
in a DMPC bilayer at 207C. PGLa has an amphi-
philic helical structure, with four charged lysines
facing one side and hydrophobic residues on the
other (helical wheel representation). Insertion can
be illustrated using the tilt angle and insertion
depth of the monomer: the helically restrained pep-
tide is initially placed into the solvent with the
charged lysine residues facing the lipid head-
groups. In the course of the simulation, the peptide
quickly flips over (0.3 ns), pointing its hydrophobic
face toward the bilayer and subsequently burying
itself in the membrane (1.3–1.8 ns). After 2.2 ns,
a stable interfacial state is reached, and this state
is used as the starting configuration for follow-up
unrestrained simulations at 35C.
Aggregation of PGLa 473observed also for many other antimicrobials, such as the
related MSI-103 (25–27) and the cell-penetrating peptide
MAP (28, and see (52)).
The critical P/Ls of the S-to-T-state transition of these
peptides were measured using oriented circular dichroism
spectroscopy (OCD) in fully hydrated DMPC bilayers, and
they ranged from P/L ¼ 1:80 for PGLa to 1:160 for MAP
and 1:240 for MSI-103 (28). Thus, the S-to-T-state realign-
ment upon increasing the peptide concentration appears to
be an important general feature of these types of amphiphilic
helices. The distinct tilt angle suggests the formation of a
stable dimer, with a characteristic helix-association angle.
The observation of only one set of NMR splittings suggests
that this dimer must be symmetric and antiparallel (21). The
interpretation of the NMR data as dimers was supported by
earlier observations that magainins and their relatives have
a tendency to dimerize, as observed for PGLa in lipid mono-
layers at the air-water interface (29), MSI-103 (25), and
MAG2 (30,31) and suggested for melittin (32).
The goal of theMD simulations performed here is to detect
the concentration-dependent realignment of PGLa, to char-
acterize the monomeric S-state and the putative dimeric T-
state, and to compare these with the experimental NMRdata. In addition, the simulations provide important structural
information complementing the solid-state NMR data, such
as the depth of insertion of the monomer/dimer, the packing
of the dimerization interface, and the detailed peptide-lipid
interactions that stabilize PGLa within the lipid bilayer.
Recently, high-temperature MD simulations have been
shown to be useful in overcoming the sampling limitations
that have rendered simulation of membrane-active peptides
difficult to achieve in the past (33,34). We present here
a straightforward application of this newprotocol to the simu-
lation of PGLa in a lipid bilayer under conditions identical to
those of the solid-state NMR experiments. This complemen-
tary experimental/computational approach is vital to advance
our understanding of this important class ofmembrane-active
peptides. The ultimate aim is to identify the specific physico-
chemical properties that lead to the antimicrobial function,
and thus to allow both prediction and improvement of the
therapeutic impact of new peptide sequences.METHODS
All simulations were performed and analyzed using Gromacs version 4.0
(www.gromacs.org) (35) and Hippo b (www.biowerkzeug.com), using theBiophysical Journal 103(3) 472–482
474 Ulmschneider et al.CHARMM27 force field (36), the OPLS-AA force field (37), and TIP3P
water (38). The united atom lipid parameters for DMPC were taken from
Ulmschneider et al. (39). CHARMM36 all-atom lipid parameters were
used for the CHARMM simulations (40). OPLS simulations where helical
restraints were used are denoted R for full restraints and R-Gly where only
critical backbone hydrogen bonds at G7 and G11 were restrained to be
helical. No restraints are used for the CHARMM simulations. The produc-
tion runs were 2 ms for OPLS, and 1 ms for CHARMM, for both the mono-
meric (S-state) and dimeric (T-state) structures. Electrostatic interactions
were computed using particle-mesh Ewald (PME), and a cutoff of 10 A˚
was used for the van der Waals interactions. Bonds involving hydrogen
atoms were restrained using LINCS (41). Simulations were run with a
2-fs time step and neighbor lists were updated every five steps. All simula-
tions were performed in the NPT ensemble, with water, lipids, and the
protein coupled separately to a heat bath with T¼ 35C and a time constant
of tT¼ 0.1 ps using weak temperature coupling (42). Atmospheric pressure
of 1 bar was maintained using weak semi-isotropic pressure coupling with
compressibility kz ¼ kxy ¼ 4.6 $ 105 bar1 and time constant tP ¼ 1 ps
(43). The PGLa peptide (GMASKAGAIAGKIAKVALKAL-amide) was
constructed as an ideal a-helix and placed in a box 20 A˚ from a preformed
lipid bilayer made up of 72 lipids and ~30 water molecules/lipid. During the
high-temperature insertion simulations, the intrahelical hydrogen bonds
were harmonically restrained to keep the peptide helical. The united-
atom lipid molecules in the OPLS simulations result in runs ~2.5 times
faster than the CHARMM simulations, where the lipids are all-atom. All
averages in the simulation are obtained over 4000 data points sampled every
500 ps in the case of the 2-ms runs and every 250 ps in the case of the 1-ms
runs. Error bars represent the mean5 SD, obtained from block averaging
over 10 blocks.
Quadrupolar splittings were obtained from the simulations by calculating
the bond order parameter SCD:
SCD ¼

1
2

3 cos2 q 1

:
Here, the angle q is between the Ca-Cb bond of the labeled residue and
the membrane normal, which is parallel to the magnetic field (z-direction).
The quadrupolar splittings were obtained from
Dvq ¼

3
2

QCCSCD ¼ 84 kHz  SCD;
with the quadrupolar coupling constant QCC ¼ 168 kHz and the factor 1/3
coming from the fast rotation of the CD3 group around the Ca-Cb bond. The
splittings can be fitted with a theoretical model to obtain the orientational
angles t and r, plus the dynamics parameter Smol, using a procedure
described previously (13).RESULTS
Rapid unbiased determination of the surface-
bound state
We have recently shown that the structure of membrane-
active peptides can be obtained from direct folding-
partitioning simulations, starting from arbitrary unfolded
conformations and using fully detailed all-atom models
(33,34). Here, we have used an even quicker alternative
based on highly elevated temperatures. The key steps are
illustrated in Fig. 1. The peptide was helically restrained
and initially placed ~20 A˚ away from the lipid bilayer.
A short, 4-ns simulation was performed at very high temper-Biophysical Journal 103(3) 472–482ature (207C). The peptide rapidly rearranged and inte-
grated itself into the membrane. The final state was
reached after 2.2 ns: the amphipathic peptide partitioned
into the bilayer interface, with the charged lysine residues
pointing into the polar headgroup region, whereas its hydro-
phobic face was entirely buried in the hydrophobic core of
the membrane. This state was stable throughout the rest of
the high-temperature run, and no further transitions were
observed. Subsequent simulations were performed by cool-
ing the system down to 35C and removing the helical
restraints.
The high-temperature insertion protocol is a computa-
tional technique that is not expected to mirror any real-life
behavior but is used to overcome kinetic entrapment in
the simulations. For example, for T < 200C, the helix
does not partition deeply into the membrane and remains
partially solvated in a position much higher than the
membrane-buried location. Insertion of the peptide causes
a mismatch in bilayer-leaflet density. This density imbal-
ance is a key feature of AMPs at high P/L. However, since
the size of the bilayer patch in the simulations is in general
much bigger than the size of the peptide, we find that this
mass imbalance does not affect the peptide structure, orien-
tation, or insertion depth in any significant way: Simulations
for the dimeric T-state where six lipid molecules were
deleted in the leaflet containing the peptide revealed no
pronounced difference from when the bilayer was left
symmetric (Fig. S1 in the Supporting Material).Monomeric S-state
Starting from the final structure of the high-temperature
insertion protocol, monomeric PGLa was simulated at the
experimental temperature (T ¼ 35C) for 2 ms (OPLS)
and 1 ms (CHARMM). These runs mimic the low-concentra-
tion NMR conditions (P/L ¼ 1:200), under which the
peptide is not expected to exist in any oligomeric state.
Fig. 2 reveals that the CHARMM simulation shows a full
a-helix, whereas PGLa partially unfolds in the OPLS
simulation, with an overall ~73% helicity. The structural
reason for the transitions to perturbed-helix states can be
found by plotting the overall helicity for each residue aver-
aged over the entire 2 ms. The helix is destabilized at the
two glycine positions, G7 and G11, where the backbone
hydrogen bonds are open to polar interfacial groups and
water molecules. The loss of helical structure is more
pronounced than in the NMR experiments, in which some
instability was seen only in the C-terminal region of PGLa
(residues A17 and A20), whereas an ideal helix was derived
between residues A6 and V16 (16). Thus, on the micro-
second scale, CHARMM seems to agree with the experi-
mental secondary-structure propensity of PGLa. Three
additional control simulations of 2-ms length each were per-
formed to investigate these force-field issues (see Support-
ing Material).
FIGURE 2 Structure (A) and orientation (B) of PGLa in the S-state. (A)
The CHARMM simulation (red) reveals a full a-helix, whereas PGLa
partially unfolds in the OPLS simulation (black), with loss of helicity prom-
inent at G7 and G11. (B) The orientation is described by two angles: the tilt
angle (t) is the angle between the membrane normal and the helix long axis,
which is defined to point from the N- to the C-terminus. The azimuthal rota-
tion angle (r) is defined as a right-handed rotation around the helix long
axis, with 0 defined to place the vector from the helix axis to the Ca
atom of K12 parallel to the membrane plane. Both angles show similar
behavior in the CHARMM and helically restrained (R) OPLS simulations.
The rotation angle slowly fluctuates over a wide range at 35C (orange
vector, blue curves), resulting in large uncertainties in r. Convergence
can be accelerated by use of high temperature (120C) using a helically
restrained peptide (R), which yields rapid convergence of t and r without
noticeably changing the averages obtained at 35C.
Aggregation of PGLa 475Fig. 3 shows the time-averaged orientation of PGLa in the
S-state simulations, which is described in terms of the helix
tilt angle, t, and the azimuthal rotation angle, r. A 2D histo-
gram plot as a function of these angles reveals overall aver-
ages that are very close to the 2H-NMR results of t z 95
and r z 116 indicated by the red dots. It is apparent
from the simulations that the peptide cannot deviate much
from these ideal values, as tilting or rotating further would
result in a deeper burial of one of the charged lysine side
chains into the hydrophobic core of the membrane, which
is energetically strongly disfavored. Although the tilt angle
has a narrow distribution close to the NMR result, r slowly
transits over a wide range (Fig. 2 B, lower), resulting in slow
convergence of the average value at 35C.
Insight can be gained by computing the orientational
angles for the Ca-Cb vectors of the individual residues,
which are proportional to the quadrupolar splitting of thecorresponding Ala-d3 label, and comparing them to the
2H-NMR data. Plots of jDnqj predicted from the simulations
of monomeric PGLa in the S-state are shown in the lower
part of Fig. 3 (red squares). Also shown are the solid-state
2H-NMR splittings from Ala-d3-labeled PGLa in DMPC
at P/L ¼ 1:200 (16,19,21) (Fig. 3, gray triangles). The
best fit to a helical wave is also plotted, with the computed
splittings yielding reasonable fits to the model (~2.9–3.3
kHz RMSD). Achieving a better match of quadrupolar split-
ting between experiment and simulation is challenging, as
has been noted before (44,45). The standard deviations of
the computed splittings, sjDnqj are large (~20 kHz) due to
the big fluctuation of r. However, the averages of jDnqj
converge to accurate values, which can be seen by the small
error bars (sjDnqj
mean) obtained from block averaging.Concentration-dependent alignment of PGLa
in the lipid bilayer
Solid-state 2H-, 15N-, and 19F-NMR measurements of PGLa
in DMPC indicate that upon an increase of peptide concen-
tration to P/L ¼ 1:50, a transition occurs from the mono-
meric S-state to a tilted T-state, with t z 127 and
a rotation angle of rz 111 (13,16,19,21). The exact struc-
ture of this state is not known. Experimentally, it is stable
over a wide range of peptide concentrations from 1:100 up
to 1:20 and independent of lipid charge (21). This hints at
the formation of a peptide dimer with a characteristic
helix-association angle that could explain the increased
tilt. Dimerization is also supported by the stepwise change
of the NMR splittings with peptide concentration (and
with temperature (24)), ruling out a gradual realignment
that might be observed if the peptide remained monomeric
(19). A loss of helical structure can be excluded from the
NMR data and CD experiments, indicating that the ob-
served changes cannot be attributed to any conformational
transitions either (19,21). Thus, the T-state is very likely
dimeric. The presence of a single set of NMR splittings indi-
cates that this dimer must be rotationally symmetric with
respect to the membrane normal, suggesting an antiparallel
dimer (19).
Can such a dimer directly be found using current micro-
second-scale MD simulations? To explore this question,
two monomers were inserted into a DMPC bilayer using
the same high-temperature protocol as for the S-state
(Fig. S4). Ideally, dimer formation would be studied by
allowing the two peptides to spontaneously assemble until
a stable contact free-energy minimum is reached. However,
currently, it is computationally challenging to perform such
simulations, as illustrated in Fig. 4. At ambient temperature,
the two peptides (initially placed 20 A˚ from each other)
diffuse very slowly in the membrane plane, with little
change of their distance over ~100 ns (Fig. 4 A). The
slow speed of the lateral movement can be overcome by
heating the system to 150C, where the peptides drift andBiophysical Journal 103(3) 472–482
FIGURE 3 Orientation and quadrupolar split-
tings jDvqj obtained from the MD simulation of
PGLa in the S-state. Two-dimensional histogram
plots of t and r, averaged over the entire simula-
tion are shown. The averages for the 1- to 2-ms
simulations are close to the NMR results (red
dots) of t z 95 and r z 116. jDnqj from Ala-
d3-labeled PGLa in DMPC at P/L ¼ 1:200 are
shown as gray triangles (16), with the number of
the labeled residue indicated and the gray line cor-
responding to the fitted helical wave. Computed
jDnqj values are shown in red, with the best fit rep-
resented by a red line. RMSD values represent the
quality of the fit to the computational data. The
computational values have huge standard devia-
tions (sjDnqjz 20 kHz) due to the large fluctuation
of r. However, the averages of jDnqj converge to
very accurate values, as illustrated by the small
error bars sjDnqj
mean obtained from block aver-
aging.
476 Ulmschneider et al.reorient more rapidly (Fig. 4 B). However, dimer formation
is not observed, presumably because dimers are not stable at
this temperature. In light of these results, the preferred
strategy for predicting dimers is to start the simulations
from various self-assembled states and judge the structures
according to their fitness to retain a thermodynamically
stable conformation. This strategy was pursued for two
initial structures (for details of the dimer setup, see
Fig. S5). The parallel dimer is shown in Fig. 4 C. This
structure was not stable: the two helices slowly minimized
their contact surface, and the center-of-mass distance con-
tinuously increased. Indeed, such an arrangement can be
excluded from the NMR data, in which only one set of
NMR splittings is observed, pointing to an antiparallel
dimer (19). PGLa is unlikely to form parallel dimers due
to its sequence: the two lateral sides of the membrane-
bound helix are not symmetric, with one face consisting
of small residues (G7, A10, G11, and A14), whereas the
opposite face is made up of bulky hydrophobic residues
(I9, I13, and V16) (Fig. 1). Close packing is thus much
more likely with an antiparallel setup involving an interface
consisting of the Ala and Gly residues. Were the dimers to
assemble via packing of the bulky hydrophobic side chains
of I9 and I13, this packing would have been disturbed by
their mutations to Ala-d3 in the NMR experiments, leading
to a strongly deviating splitting, which was not observed
(19,21).Biophysical Journal 103(3) 472–482Dimeric T-state
When constructed as a symmetric antiparallel dimer, a stable
structure was found in the simulations (Figs. 5 and 6). The
quadrupolar splittings, jDnqj, for the T-state at 35C are
shown in Fig. 5 and compared with the solid-state 2H-
NMR data from Ala-d3-labeled PGLa in DMPC at P/L ¼
1:50. The overall match is not as good as for the S-state,
which can be traced to a lower tilt angle encountered in
the simulations compared to the experiments. Similar to
the NMR results, MD simulations show that the helices
increase their tilt angle in the T-state, though the increase
to t z 104–107 is not as high as the t z 127 found in
the NMR analysis. Two sets of splittings exist from the
two chains, but the values are almost identical, agreeing
with the experimental hypothesis. Despite this, the fitting
procedure can give quite distinct results (CHARMM),
demonstrating the difficulty of arriving at a perfect match
between simulation and experiment. The stable dimeriza-
tion interface exhibits close van der Waals contacts of
G11-G11, flanked on either side by two A10-A14 pairings
(Fig. 6). These small residues allow the two helices to
pack very closely together, whereas the bulky hydrophobic
residues on the opposing face (I9, I13, and V16) make
contact with the lipid hydrocarbon tails of the membrane.
The CHARMM dimer is slightly shifted from the OPLS
dimer, but without alteration of the close G11-G11 and
FIGURE 4 Dimerization simulations of two PGLa peptides in a DMPC
bilayer, viewed from above the membrane surface. Representative struc-
tures are shown, with the center-of-mass distance of the two peptides
plotted versus simulation time. (A) Spontaneous aggregation is slow and
not observed at 35C, with the two peptides remaining at a constant
distance. (B) Upon heating to 150C, the peptides diffuse and rotate rapidly
in their monolayer, but aggregation is disfavored. (C) An initially parallel
dimer is not thermodynamically stable and quickly dissolves (red, reference
distance of the stable antiparallel dimer).
Aggregation of PGLa 477A10-A14 contacts. Given the large differences in the force
fields, small dissimilarities like these are expected. All lysine
side chains face upwards into the polar lipid headgroup
region, as in the S-state. This finding is fully compatible
with the marginal change observed for the azimuthal rotation
angle, from r z 116 to r z 111. Positional root mean-
square fluctuations (RMSF) of each residue over the course
of the simulation indicate generally larger fluctuations for
C-terminal residues than for residues 1–20 (Fig. 6).
As shown in Fig. 7, the simulations show monomeric
PGLa to be deeply buried below the lipid phosphate and
glycerol/carbonyl region. The peptide remains at this buried
position in the membrane throughout the simulation, with
a center of mass zCM ¼ 9.4 A˚ from the center of the bilayer
and only a small fluctuation of 51 A˚ along the membrane
normal. This location embeds the hydrophobic residues
firmly in the membrane interior, whereas the charged lysine
side chains are fully extended into the polar lipid phos-
phocholine region. Peptide positions any higher up in the
bilayer are not observed in the simulations. A similar deepburial is seen for the T-state dimer. The introduction of
such a large and highly charged complex into the membrane
causes a considerable surface distortion of the lipid phase
(Fig. 7) and a severe local thinning (5 A˚) of the bilayer
is seen in the bilayer leaflet containing the peptide.DISCUSSION
The S- to T-state realignment of PGLa with increased
peptide concentration was first found experimentally and
is studied here via MD simulations. This transition is likely
described as the formation of antiparallel dimers. The simu-
lation-derived tilt and rotation angles, as well as the quadru-
polar splittings for both the monomeric S-state and the
dimeric T-state, match those derived from solid-state 2H-,
15N-, and 19F-NMR spectroscopy (16,19,21), with an overall
better agreement for the S-state than the T-state. What the
simulations demonstrate is that PGLa can form such dimers,
and that dimerization increases the tilt angle (independent of
chosen force field), so this is the likely cause of the increase
seen in the NMR experiments at high P/L. Ab initio predic-
tion of dimers in membranes is very challenging and has
been recently attempted for the TM dimerization of glyco-
phorin A (46–49) and integrins (50). These studies em-
ployed helically restrained coarse-grained models and the
final dimeric structure was verified using atomistic MD
for only very short sampling times (~50 ns). Our study
goes beyond those efforts in verifying that the candidate
structure is stable for 1–2 ms of MD. Current computational
limitations unfortunately prevent a more thorough confor-
mational search, so it is possible that other antiparallel
dimeric structures might exist that are also stable. These
issues will be addressed in the future by even longer simu-
lations in the ~10–20 ms range.
Dimer formation appears to be an important property of
this class of long helical AMPs, and it has also been
observed for the model peptide MSI-103 (25,26), for
MAG2 (30), for melittin (32), for PGLa in lipid monolayers
at the air-water interface (29), in 1:1 mixtures of PGLa with
MAG2 (51), and for the cell-penetrating peptide MAP (52).
The transition to the dimeric state occurs at high peptide
concentration, with critical values ranging from P/L ¼
1:80 to 1:240 for these AMPs in DMPC bilayers, as deter-
mined by oriented CD (28). Interestingly, at intermediate
peptide concentrations (P/L ¼ 1:100) in DMPC bilayers,
PGLa monomers and dimers can coexist as an equilibrium
with fast exchange between the states (21). For the T-state
dimer of PGLa, we find a crossing angle of ~29–33 for
the two antiparallel helices, with a close contact involving
strong van der Waals interactions between the small hydro-
phobic amino acid residues G7, G11, A10, and A14. Such
an interface is supported by the 2H-NMR measurements,
which found no structural disturbance when mutating the
residues I9 and I13 on the opposite face of the peptide
(13). Similar contacts involving the A10 and A14 residuesBiophysical Journal 103(3) 472–482
FIGURE 5 Concentration-dependent realign-
ment and dimerization of PGLa in the lipid
bilayer. Solid-state NMR measurements have re-
vealed a change of orientation from the monomeric
surface-bound S-state at low P/L molar ratio
(P/L ¼ 1:200) to an obliquely tilted T-state with
increasing peptide concentration (P/L ¼ 1:50).
The T-state is presumed to be an antiparallel dimer.
The final structures, as well as the tilt angles from
the 2-ms MD simulations of the S-state and T-state
at 35C, are shown (upper). Two-dimensional
histogram plots as a function of the tilt (t) and rota-
tion (r) angle of the T-state are shown below, as are
the quadrupolar splittings jDnqj and fitted helical
waves (gray triangles, experimental data; red/
orange squares, simulation results). Similar to
the NMR results (t z 127 and r z 111 (red
dots)), the helices are found to tilt more in the
T-state than in the S-state (histogram insets),
though the increase is not as large as that found
in the NMR analysis. The error bars of jDnqj repre-
sent sjDnqj
mean obtained from block averaging. The
RMSD of the fit is large, and tiny differences in the
splittings between the two chains result in very
different fits for the CHARMM simulations.
478 Ulmschneider et al.were reported for the proposed parallel dimer of the analo-
gous peptide MSI-103, which has a sequence derived from
PGLa (25). The crossing angle in this case was ~20.
Recently, several computational studies of related antimi-
crobial peptides have been reported, for example for magai-
nin (MAG-H2) (53), melittin (54), and cateslytin (55), in
which a variety of disordered structural aggregates were
found both for interfacial and membrane-inserted pore
states. No specific interfacial assemblies such as dimeric
T-states were encountered. In addition, the peptides were
found to be only marginally a-helical: For example, 40–
50% helicity for melittin was reported, compared to the
experimental value of ~50–70% (54). These results differ
qualitatively from the NMR data for PGLa, in which it
appears highly helical, with well-ordered, distinct structures
exhibiting clearly defined tilt and rotation angles (16). The
formation of large peptide aggregates at high P/L—indica-
tive of a carpetlike model (56)—is not supported by the
observed fast rotational diffusion of PGLa around the
membrane normal, which instead supports formation of
dimers (13,19). Only at the highest peptide concentrationsBiophysical Journal 103(3) 472–482(P/L > 1:20) does PGLa seem to become immobilized in
DMPC by the lateral crowding, but these assemblies never-
theless retain the well-defined orientation of the dimeric
T-state (21).
We have shown here that some of the disparity in the
various simulation results of AMPs can be traced to the
simulation force field. The CHARMM simulations show
perfectly helical PGLa in both S- and T- states, in agreement
with the NMR data, whereas the OPLS simulations reveal
partial loss of secondary structure. These results highlight
the importance of choosing both balanced simulation
parameters and long sampling times (ms) if accurate com-
parison to experimental data is the goal. Recent findings also
show that the outcome of the simulations of membrane-
active peptides is greatly influenced by the choice of the
electrostatic long-range models, and by the inclusion or
omission of counterions (57). Moreover, studies of hydro-
phobic WALP peptides (which are of similar length to
AMPs) in lipid bilayers have revealed that unphysical
helical unfolding can occur on the microsecond scale if
protein and lipid parameters are not properly balanced
FIGURE 6 (A) Dimeric T-state of PGLa. Shown are representative structures of the antiparallel dimer taken from the simulations. The dimerization inter-
face is made up of the small central residues G11 and G7 (green) and A10 and A14 (purple). This allows the two helices to closely pack together in a stable
structure, which does not change during 2 ms for the OPLS (R-Gly) and 1 ms for the CHARMM simulation. A contact map shows the time-averaged distance
of the interhelix residue contacts. Positional root-mean-square fluctuations (RMSF) of each residue over the course of the simulations reveal that the peptide is
much more flexible in the OPLS (R-Gly) than in the CHARMM simulation.
Aggregation of PGLa 479(33,39,58,59). Even if parameters are good, it is challenging
to achieve quantitative agreement between experimental
and computed quadrupolar splittings for membrane-bound
peptides such as WALP (44,45).
The T-state may represent an intermediate stage in the
formation of the proposed transmembrane pores (or fully in-
serted I-states) of PGLa. These are expected to consist of
groups of such dimers assembled into larger toroidal pores,
in which the cationic residues of the peptides together
with anionic lipid headgroups line a water-filled channel
(11,16,21). No such state has yet been observed in liquidcrystalline bilayers, possibly because the pores are transient
and not stable enough to be studied by NMR, though they
are still able to cause antimicrobial activity (21). However,
recent data demonstrate that PGLa can insert into liquid
crystalline DMPC/DMPG (3:1) bilayers with a tilt angle
of ~158, when prepared as a synergistic 1:1 mixture with
MAG2 at P/L ¼ 1:50 (22). Interestingly, proton-decoupled
15N solid-state NMR measurements on similar mixtures
indicate that MAG2 remains in a stable in-plane alignment
in this arrangement (23). Short-lived pore structures can
be considered part of a general mechanism, in which theBiophysical Journal 103(3) 472–482
FIGURE 7 Insertion depth and bilayer deformation of PGLa in a DMPC lipid bilayer in the S-state and the T-state (OPLS runs). Plots of the density cross
section reveal the peptide to be deeply inserted, below the lipid phosphate (PO4) and glycerol/carbonyl (G/C) groups. Representative snapshots are shown to
scale, with the phosphate groups highlighted as orange beads. The bilayer surface distortion induced by the PGLa peptide is illustrated on the right. The
contour plots show the rotationally adjusted deviation in the time-averaged phosphate distance from the center of the bilayer for the leaflet containing
the peptide. The peptides cause a significant local thinning (up to 5 A˚) of the membrane. Results for the CHARMM simulations are similar.
480 Ulmschneider et al.initial imbalance of mass and charge on one bilayer leaflet
leads to assembly and temporary porelike structures in the
bilayer until enough peptide has accumulated on the op-
posing side of the membrane (60). Once the peptide is equil-
ibrated across the membrane, the pores are then thought
to dissipate, as evidenced by leakage assays (60). However,
such behavior has not yet been detected in the MD simula-
tions of AMPs (53–55), where the disordered membrane-
inserted porelike aggregates seemed to be the dominant state
above a certain peptide concentration and were not observed
to dissolve. Further studies will be required to answer these
questions.
MD simulations, coupled with quantitative comparisons
with solid-state NMR data, offer a practical means of ad-
dressing many of the questions concerning the mechanism
of these peptides that can otherwise only be indirectly ob-
served through functional leakage assays. Once a reliable
protocol has been established for any one type of system
on the basis of experimental NMR data, the effect of muta-
tions and chemical modifications can be elucidated in a very
efficient manner by MD simulations.SUPPORTING MATERIAL
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